Fund Houses Recommendations at a Glance (20/3/23)

Jefferies on Can Fin Home: Maintain Buy on Company, target price at Rs 635/Sh (Positive)

MS on SBI Card: Maintain Overweight on Company, target price at Rs 925/Sh (Positive)

MS on PB Fintech: Maintain Overweight on Company, target price at Rs 220/Sh (Positive)

GS on Godrej CP: Maintain Overweight on Company, target price at Rs 1100/Sh (Positive)

Axis on Zydus Life: Maintain Buy on Company, target price at Rs 560/Sh (Positive)

MS on Biocon: Maintain Overweight on Company, target price at Rs 311/Sh (Positive)

JP Morgan on DLF: Maintain Overweight on Company, target price at Rs 490/Sh (Positive)

JP Morgan on Reliance: Maintain Overweight on Company, target price at Rs 2960/Sh (Positive)

MS on GSK Pharma: Maintain Underweight on Company, target price at Rs 1256/Sh (Neutral)

(recommendation by Kunvarji)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)